The past and present role of the Sabin-Feldman dye test in the serodiagnosis of toxoplasmosis

Bulletin of the World Health Organization

Volumn 77, Issue 11, 1999, Pages 929-935

  Reiter Owona, I ^a   Petersen, E ^b   Joynson, D ^c   Aspock H ^d   Darde M L ^e   Disko, R ^f   Dreazen, O ^g   Dumon, H ^h   Grillo, R ⁱ   Gross, U ^j   Hayde, M ^k   Holliman, R ^l   Ho Yen, D O ^m   Janitschke, K ⁿ   Jenum, P A ^o   Naser, K ^p   Olszewski, M ^q   Thulliez, P ^r   Seitz, H M ^a  

^a UNIVERSITY OF BONN   (Germany)

^b STATENS SERUM INSTITUT   (Denmark)

^c SINGLETON HOSPITAL   (United Kingdom)

^d Inst fur Hyg und Med Parasitol   (Austria)

^e Laboratoire de Parasitologie   (France)

^f Inst fur Genetik und Mikrobiologie   (Germany)

^g MINISTRY OF HEALTH   (Israel)

^h TIMONE HOSPITAL   (France)

ⁱ Institute of Microbiology   (Italy)

^j UNIVERSITY OF WÜRZBURG   (Germany)

^k UNIV KLIN KINDER JUGENDHEILKUNDE   (Austria)

^l ST GEORGE S HOSPITAL   (United Kingdom)

^m RAIGMORE HOSPITAL   (United Kingdom)

ⁿ ROBERT KOCH INSTITUTE   (Germany)

^o NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^p Landesgesundheitsamt   (Germany)

^q UNIVERSITY OF ROSTOCK   (Germany)

^r Institut de Puericulture   (France)

more..

Author keywords

Antibodies, protozoan; Reference standards and values; Serological tests; Toxoplasmosis diagnosis

Indexed keywords

DYE; FUNGUS ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL LABORATORY; CLINICAL TRIAL; DIAGNOSTIC VALUE; HUMAN; MULTICENTER STUDY; SERODIAGNOSIS; STAINING; STANDARDIZATION; TOXOPLASMOSIS;

CLINICAL PROTOCOLS; EUROPE; HUMANS; ISRAEL; LABORATORY TECHNIQUES AND PROCEDURES; METHYLENE BLUE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS; SINGLE-BLIND METHOD; TOXOPLASMOSIS;

EID: 0032785346     PISSN: 00429686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Sabin AB, Feldman HA. Dyes as microchemical indicators of a new immunity phenomenon affecting a protozoon parasite (Toxoplasma). Science, 1948, 108: 660-663.
2. Schreiber RD, Feldman HA. Identification of the activator system for antibody to Toxoplasma as the classical complement pathway. Journal of infectious diseases, 1980, 141: 366-369.
3. Jettmar HM. [Detection of anti-toxoplasma properites in human serum]. Wiener klinische Wochenschrift, 1954, 66: 276-277 (in German).
4. Westphal A, Knüttgen H. [Specificity of the toxoplasmosis reaction using the Sabin-Feldman test] Medizinisch Wochenschrift, 1950, 4: 196 (in German).
5. Jacobs L, Cook MK. Variations in the dye test for toxoplasmosis. American journal of tropical medicine and hygiene, 1954, 3: 860-867.
6. Beverley JKA, Beattie CP. Standardization of the dye test for toxoplasmosis. Journal of clinical pathology, 1952, 5: 350-353.
7. Feldman HA, Lamb AG. A micromodification of the Toxoplasma dye test. Journal of parasitololgy, 1966, 52: 415.
8. Desmonts J, Remington JS. Direct agglutination test for diagnosis of Toxoplasma infection: method for increasing sensitivity and specificity. Journal of clinical microbiology, 1980, 11: 562-568.
9. Walton BC, Benchoff BM, Brooks WH. Comparison of indirect fluorescent antibody test and methylene blue dye test for detection of antibodies to Toxoplasma gondii. American journal of tropical medicine and hygiene, 1966, 15: 149-152.
10. Voller A et al. A microplate enzyme immunoassay for Toxoplasma antibody. Journal of clinical pathology, 1976, 29: 150-153.
11. Noat Y, Remington JS. An enzyme-linked immunosorbent assay for detection of IgM antibodies to Toxoplasma gondii. Use for diagnosis of acute acquired toxoplasmosis. Journal of infectious diseases, 1980, 142: 757-766.
12. Carlier Y et al. Evaluation of the enzyme-linked immunosorbent assay (ELISA) and other serological tests for the diagnosis of toxoplasmosis. Bulletin of the World Health Organization, 1980, 58:99-105.
13. WHO Expert Committee on Biological Standardization. Twentieth Report Geneva, World Health Organization, 1968 (WHO Technical Report Series, No. 384).
14. WHO Expert Committee on Biological Standardization. Thirty-first Report. Geneva, World Health Organization, 1981 (WHO Technical Report Series, No. 658).
15. Petithory JC et al. Performance of European laboratories testing serum samples for Toxoplasma gondii. European journal of clinical microbiology and infectious diseases, 1996, 15: 45-49.
16. Remington JS, Klein JO. Infectious disease of the fetus and newborn infant, 4th edit. Philadelphia, PA, W.B. Saunders, 1995: 89-174.
17. Hansen GA, Lyng J, Petersen E. Calibration of a replacement preparation for the Second International Standard for anti-Toxoplasma serum, human. Geneva, World Health Organization, 1994 (unpublished document WHO/BS/1994; available upon request from Blood Safety and Clinical Technology, World Health Organization, 1211 Geneva 27, Switzerland).
18. Cathie IAB. The non-specificity of the dye test for toxoplasmosis: with particular reference to Trichomonas infection. Great Ormond Street journal, 1955, 10: 81-85.
19. Kulasiri C. The specificity of the Sabin-Feldman dye test with reference to protozoal infections. Journal of clinical pathology, 1960, 13: 339-348.
20. Piekarski G, Seeliger HPR, Saathoff M. [Specificity of the Toxoplasma seroreaction: relationship between Toxoplasma- and Listeria-antibodies]. Zeitschrift für Hygiene, 1957, 144: 202-214 (in German).
21. Cathie IAB, Cecil GW. Sarcospores and Toxoplasma serology. An investigation of their alleged cross-reaction. Lancet, 1957, i: 816-818.
22. Bakal PM. The specificity of Sabin and Feldman's dye test in the diagnosis of toxoplasmosis. Tropical geographical medicine, 1962, 14: 56-66.
23. Liesenfeld O et al. Study of Abbott Toxo IMx System for detection of immunoglobulin G and immunoglobulin M Toxoplasma antibodies: value of confirmatory testing for diagnosis of acute toxoplasmosis. Journal of clinical microbiology, 1996, 34: 2526-2530.
24. Petithory JC et al.[Re-evaluation of 40 reagent kits for the detectioi of anti-toxoplasmosis IgG antibodies]. Revue française des laboratoires, 1998, 301: 59-64 (in French).
25. Bundesgesundheitsamt. [Recommendations for performing Toxoplasma seroreactions]. Bundesgesundheitblätter 1966, 23: 354-355 (in German).
26. Bundesgesundheitsamt. [Recommendations for performing Toxoplasma seroreactions using micromethods). Bundesgesundheitblätter 1977, 20: 108-112 (in German).
27. Fleck DG, Kwantes W. The laboratory diagnosis of toxoplasmosis. London, Her Majesty's Stationery Office, 1980 (Monograph 13).
28. Winsser J et al. Isolation of Toxoplasma from cerebrospinal fluid of a living infant in Holland. Proceedings of the Society of Experimental Biology and Medicine, 1948, 67: 292-294.
29. Weiss LM et al. Western blot analysis of the antibody response of patients with AIDS and Taxoplasma encephalitis: antigen diversity among Toxoplasma strains. Journal of infectious diseases, 1988, 157: 7-13.
30. An international standard for anti-Toxoplasma IgG and IgM antibodies. Copenhagen, World Health Organization, 1992 (unpublished document WHO/BS/92; available upon request from Blood Safety and Clinical Technology, World Health Organization, 1211 Geneva 27, Switzerland).
31. Petithory JC et al. [Serodiagnosis of toxoplasmosis: a comparative multicentre study of a series of control sera using various currently available tests and expression of the results in International Units]. Bulletin of the World Health Organization, 1996, 74: 291-298 (in French).
32. Kagan IG. Standardization and quality control of immunodiagnostic methods. Behring Institut Mitteilungen, 1982, 71: 10-22.